Russell Investments Group Ltd. Sells 82,620 Shares of The Chemours Company
June 1, 2023
☀️Trending News
The Chemours Company ($NYSE:CC) is a leading global provider of advanced chemical technologies and services. The company produces a broad range of products used in a variety of industries including automotive, aerospace, construction, electronics, food and beverage, pharmaceuticals and more. Through their innovative solutions, Chemours helps their customers use less energy and water, reduce emissions and improve the quality of life for people around the world.
The company’s portfolio includes titanium dioxide, fluoroproducts, fluoropolymers and other performance chemicals. Their products are used in everyday life from helping to keep food fresh and safe to powering electric cars and providing essential ingredients for pharmaceuticals.
Price History
The transaction was disclosed in a legal filing with the SEC. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Chemours Company. More…
| Total Revenues | Net Income | Net Margin |
| 6.57k | 489 | 7.6% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Chemours Company. More…
| Operations | Investing | Financing |
| 633 | -271 | -569 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Chemours Company. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.62k | 6.4k | 8.23 |
Key Ratios Snapshot
Some of the financial key ratios for Chemours Company are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 6.4% | 15.1% | 12.2% |
| FCF Margin | ROE | ROA |
| 5.2% | 42.7% | 6.5% |
Analysis
At GoodWhale, we thoroughly analyze investments for our users. For instance, let’s take a look at CHEMOURS COMPANY. After analyzing their financials, we can see that based on our Risk Rating, this company is a medium risk investment in terms of financial and business aspects. Furthermore, our system has detected two risk warnings in their balance sheet, which are non-financial in nature. If you are interested in learning more about these risks and getting better informed about your investments, then simply register with us to check it out. We are here to help you make sure that your investments are sound and secure. More…
Peers
The Chemours Co, Green Earth Institute Co Ltd, Mitsui Chemicals Inc, and AlzChem Group AG are all competitors in the chemical industry. Chemours is a holding company that produces chemicals and related products, while Green Earth is a research institute focused on developing environmentally friendly alternatives to traditional chemicals. Mitsui Chemicals is a Japanese company that produces a wide variety of chemicals, while AlzChem Group is a German company specializing in inorganic and specialty chemicals.
– Green Earth Institute Co Ltd ($TSE:9212)
Green Earth Institute Co Ltd is a company that focuses on environmental protection. It has a market cap of 6.98B as of 2022 and a Return on Equity of -20.43%. The company has been struggling financially in recent years, which is reflected in its ROE. However, it remains committed to its environmental protection mission.
– Mitsui Chemicals Inc ($TSE:4183)
Mitsui Chemicals Inc. is a Japanese chemical company with a market cap of 530.73B as of 2022. The company has a Return on Equity of 12.55%. Mitsui Chemicals Inc. is engaged in the manufacture and sale of chemicals and plastics. The company’s products include polymers, resins, films, fibers, and other chemicals. Mitsui Chemicals Inc. has operations in Japan, Asia, Europe, and the Americas.
– AlzChem Group AG ($LTS:0ACT)
AlzChem Group AG is a German chemical company with a market cap of 152.04M as of 2022. The company has a Return on Equity of 20.28%. AlzChem Group AG produces specialty chemicals for the pharmaceutical, agrochemical, and polymer industries. The company was founded in 1894 and is headquartered in Trostberg, Germany.
Summary
Chemours Company is a chemical company that manufactures titanium dioxide and fluorochemicals. Russell Investments Group Ltd recently sold 82620 shares of the company, indicating a bearish outlook on the stock. Analysts have noted that Chemours Company has seen a steady decline in revenues over the past few years.
In light of these factors, investors should proceed with caution when considering an investment in Chemours Company. Furthermore, investors should consider diversifying their portfolio and researching other companies in the same industry before investing in Chemours Company.
